This April and May, 20 iLab teams have completed the mid-term report of the 2022 Fudan MBA iLab Business Consulting Projects.
Teams working with Glosic (Shanghai) Semiconductor, Takeda China and Modulight Corp. have been focus on the integration of technology innovation and healthcare.
The Glosic (Shanghai) Semiconductor project team has been helping the company break through the financial bottleneck. The team realizes that although the company owns key advantages in terms of technology, supply, etc., it hasn’t yet differentiated itself from similar start-ups. In addition, the founder does not know much about the development path of the capital market, and needs professional assistance in analysis and planning. In the next stage, the team will begin to formulate financial plans from the perspective of finance and business operations.
The Takeda China team helps the company to develop strategies for the digital marketing of innovative drugs in the field of oncology. Now the team has decided on five potential directions of the digital marketing strategies, and will use the patient journey as a tool and a basis for researches of the next stage, and plan to further investigate the possible integration of the five directions.
The Modulight Corp. team has been exploring the China market entry strategies of light activated drugs for the company. Given that in the domestic market, the acceptance rate of this new therapy is rather low and that experts haven’t reached a consensus, providing with an operational and customised market entry plan has been extremely challenging for the team. Yet the team members are highly motivated and have done in-depth researches in three directions.
